Peptidoglycan and peptidoglycan-specific Th1 cells in psoriatic skin lesions

Journal of Pathology

Volumn 209, Issue 2, 2006, Pages 174-181

  Baker, B S ^a   Laman, J D ^b   Powles, A ^a   van der Fits, L ^b   Voerman, J S A ^b   Melief, M J ^b   Fry, L ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Antigen presentation; Gram positive bacteria; Psoriasis; Skin inflammation; T cell cytokines

Indexed keywords

CD4 ANTIGEN; CD68 ANTIGEN; CELL MARKER; CYTOKINE; GAMMA INTERFERON; HLA DR ANTIGEN; PEPTIDOGLYCAN; SUPERANTIGEN;

ALLELE; ANTIGEN PRESENTING CELL; ANTIGEN SPECIFICITY; ARTICLE; CELL ACTIVATION; CELL COUNT; CELL LINE; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOSTIMULATION; IN SITU HYBRIDIZATION; LANGERHANS CELL; LYMPHOCYTE PROLIFERATION; LYMPHOCYTIC INFILTRATION; MACROPHAGE; MITOGENICITY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PSORIASIS; SKIN DEFECT; STAPHYLOCOCCUS; STREPTOCOCCUS; T LYMPHOCYTE; TH1 CELL;

ANTIGEN-PRESENTING CELLS; CELL DIVISION; CELL LINE; HLA-DR ANTIGENS; HUMANS; IMMUNOHISTOCHEMISTRY; INTERFERON TYPE II; LEUKOCYTES, MONONUCLEAR; MACROPHAGES; PEPTIDOGLYCAN; PSORIASIS; SKIN; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PYOGENES; TH1 CELLS;

EID: 33744460804     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.1954     Document Type: Article

References (34)

1. Bowcock AM, Cookson WOCM. The genetics of psoriasis, psoriatic arthritis and atopic dermatitis. Hum Mol Genet 2004;13:R43-R55.
2. Norholm-Pedersen A. Infections and psoriasis. Acta Dermatol Venereol (Stockh) 1952;32:159-167.
3. Whyte HJ, Baughman RD. Acute guttate psoriasis and streptococcal infection. Arch Dermatol 1964;89:350-356.
4. Norrlind R. Significance of infections in origin of psoriasis. Acta Rheumatol Scand 1955;1:135-144.
5. Cohen-Tervaert WC, Esseveld H. A study of the incidence of haemolytic streptococci in the throat in patients with psoriasis vulgaris, with reference to their role in the pathogenesis of this disease. Dermatologica 1970;140:282-290.
6. Baker BS, Bokth S, Powles A, Garioch J, Lewis H, Valdimarsson H, et al. Group A streptococcal antigen-specific T lymphocytes in guttate psoriatic lesions. Br J Dermatol 1993;128:493-499.
7. Baker BS, Brown DW, Porter W, Hardman C, Garioch JJ, Powles A, et al. T lymphocytes reactive for group A streptococcal antigens in chronic plaque psoriatic lesions. Arch Dermatol Res 1999;291:564-566.
8. Vollmer S, Menssen A, Trommler P, Schendel D, Prinz JC. T lymphocytes derived from skin lesions of patients with psoriasis vulgaris express a novel cytokine pattern that is distinct from that of T helper type 1 and T helper type 2 cells. Eur J Immunol 1994;24:2377-2382.
9. + subsets. J Invest Dermatol 1998;111:1072-1078.
10. + T cells produce interferon-gamma in vitro in response to streptococcal antigens in chronic plaque psoriasis. J Invest Dermatol 2000;114:576-580.
11. + T cells in psoriasis. Arch Dermatol Res 2001;293:165-170.
12. Baker BS, Ovigne J-M, Fischetti VA, Powles AV, Fry L. Selective response of dermal Th-1 cells to 25-50 kDa streptococcal cell wall proteins in chronic plaque psoriasis. Scand J Immunol 2003;58:335-341.
13. Moreillon P, Majcherczyk PA. Proinflammatory activity of cell-wall constituents from Gram-positive bacteria. Scand J Infect Dis 2003;35:632-641.
14. Aly R, Maibach ME, Mandel A. Bacterial flora in psoriasis. Br J Dermatol 1976;95:603-606.
15. Simelyte E, Rimpilainen M, Zhang X, Toivanen P. Role of peptidoglycan subtypes in the pathogenesis of bacterial cell wall arthritis. Ann Rheum Dis 2003;62:976-982.
16. Johnson PM, Phua KK, Perkins HR, Hart CA, Bucnall RC. Antibody to streptococcal cell wall peptidoglycan-polysaccharide polymers in seropositive and scronegative rheumatic disease. Clin Exp Immunol 1984;55:115-124.
17. Schrijver IA, Melief M-J, Markusse HM, Van Aelst I, Opdenakker G, Hazenberg MP, et al. Peptidoglycan from sterile human spleen induces T-cell proliferation and inflammatory mediators in rheumatoid arthritis patients and healthy subjects. Rheumatology (Oxford) 2001;40:438-446.
18. Rantakokko K, Rimpilainen M, Uksila J, Janssen C, Luukkainen R, Toivanen P. Antibodies to streptococcal cell wall in psoriatic arthritis and cutaneous psoriasis. Clin Exp Rheumatol 1997;15:399-404.
19. Kool J, De Visser H, Gerrits-Boeye MY, Klasen IS, Melief MJ, Van Helden-Meeuwsen CG, et al. Detection of intestinal flora-derived bacterial antigen complexes in splenic macrophages of rats. J Histochem Cytochem 1994;42:1435-1441.
20. Travassos LH, Girardin SE, Philpott DJ, Blanot D, Nahori MA, Werts C, et al. Toll-like receptor 2-dependent bacterial sensing does not occur via peptidoglycan recognition. EMBO Rep 2004;5:1000-1006.
21. Schrijver IA, Melief M-J, Tak PP, Hazenberg MP, Laman JD. Antigen-presenting cells containing bacterial peptidoglycan in synovial tissues of rheumatoid arthritis patients coexpress costimulatory molecules and cytokines. Arthritis Rheum 2000;43:2160-2168.
22. Baker BS, Ovigne J-M, Fischetti VA, Powles AV, Fry L. Reduced IFN-γ responses associated with HLA-DR15 presentation of streptococcal cell wall proteins to dermal Th-1 cells in psoriasis. J Clin Immunol 2003;23:407-414.
23. Schrijver IA, van Meurs M, Melief M-J, Wim Ang C, Buljevac D, Ravid R, et al. Bacterial peptidoglycan and immune reactivity in the central nervous system in multiple sclerosis. Brain 2001;124:1544-1554.
24. Laman JD, Schoneveld AH, Moll FL, van Meurs M, Pasterkamp G. Significance of peptidoglycan, a proinflammatory bacterial antigen in atherosclerotic arteries and its association with vulnerable plaques. Am J Cardiol 2002;90:119-123.
25. Visser L, Jan de Heer H, Boven LA, van Riel D, van Meurs M, Melief MJ, et al. Proinflammatory bacterial peptidoglycan as a cofactor for the development of central nervous system autoimmune disease. J Immunol 2005; 174:808-816.
26. Philpott DJ, Girardin SE. The role of Toll-like receptors and Nod proteins in bacterial infection. Mol Immunol 2004;41:1099-1108.
27. Girardin SE, Hugot H-P, Sansonetti PJ. Lessons from Nod2 studies: towards a link between Crohn's disease and bacterial sensing. Trends Immunol 2003;24:652-658.
28. Lee FI, Bellamy SV, Francis C. Increased incidence of psoriasis in patients with Crohn's disease and their relatives. Am J Gastroenterol 1990;85:962-963.
29. Granucci F, Ricciardi-Castagnoli P. Interactions of bacterial pathogens with dendritic cells during invasion of mucosal surfaces. Curr Opin Microbiol 2003;6:72-76.
30. Wardrop P, Weller R, Marais J, Kavanagh G. Tonsillitis and chronic psoriasis. Clin Otolaryngol 1998;23:67-68.
31. Gudjonsson JE, Thorarinsson AM, Sigurgeirsson B, Kristinsson KG, Valdimarsson H. Streptococcal throat infections and exacerbation of chronic plaque psoriasis: a prospective study. Br J Dermatol 2003;149:530-534.
32. Osterlund A, Popa R, Nikkila T, Scheynius A, Engstrand L. Intracellular reservoir of Streptococcus pyogenes in vivo: a possible explanation for recurrent pharyngotonsillitis. Laryngoscope 1997;107:640-647.
33. Nakagawa Y, Murai T. Staphylococcal peptidoglycan suppresses production of IL-2 by T cells through a T cell-derived factor induced by direct contact between T cells and monocytes. J Infect Dis 2003;188:1284-1294.
34. Fischer W, Koch U, Rosel P, Fiedler F, Schmuck L. Structural requirements of lipoteichoic acid carrier for recognition by the Poly(ribitol phosphate) polymerase from Staphylococcal aureus H. J Biol Chem 1980;255:4550-4556.